Kendall Wagner, MD
Internal Medicine · Fort Smith, ARNPI 1699091264
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,640 of the $5,957 with a category attached, or 61.1%. Corium, LLC accounts for 77.8% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2024 at $4,092 and has fallen 90.7% since, to $380 in 2025. Among internal medicine clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 111 payments — averaging $53.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$5K
- Kowa Pharmaceuticals America, Inc.$181
- Mirum Pharmaceuticals, Inc.$142
- Ironshore Pharmaceuticals Inc.$127
- Merck$81
- Amarin Pharma, Inc.$75
- plus $717 from 18 others
What the payments were for
- Consulting fees$3,64061%
- Travel & lodging$57210%
- Food & beverage$1,74529%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 30 | $4,634 |
| Kowa Pharmaceuticals America, Inc. | 14 | $181 |
| Mirum Pharmaceuticals, Inc. | 6 | $142 |
| Ironshore Pharmaceuticals Inc. | 7 | $127 |
| Merck | 6 | $81 |
| Amarin Pharma, Inc. | 4 | $75 |
| GSK | 6 | $74 |
| Novo Nordisk | 4 | $69 |
| Supernus Pharmaceuticals, Inc. | 4 | $65 |
| Pfizer | 4 | $60 |
| AbbVie(2 entities) | 4 | $60 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| Biohaven Pharmaceuticals, Inc. | 2 | $53 |
| Sanofi Pasteur Inc. | 2 | $48 |
| Sanofi-aventis U.S. LLC | 2 | $46 |
| Alfasigma USA, Inc. | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $30 |
| Teva Pharmaceuticals USA, Inc. | 2 | $27 |
| Revance Therapeutics, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Phadia US Inc. | 1 | $16 |
| AstraZeneca | 1 | $14 |
| Bayer | 1 | $13 |
| Boehringer Ingelheim | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Azstarys$4,042
How this compares
$5,957 in reported general payments places this provider in the 90th percentile of 614 internal medicine providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rufinamide | 13 | $25,423 |
| OzempicSemaglutide | 24 | $25,346 |
| JardianceEmpagliflozin | 14 | $10,556 |
| Levetiracetam | 56 | $3,476 |
| Divalproex Sodium | 11 | $3,332 |
| Carbamazepine ErCarbamazepine | 32 | $3,274 |
| Glycopyrrolate | 47 | $1,865 |
| Baclofen | 66 | $1,534 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $1,172 |
| Sucralfate | 15 | $1,032 |
| Medroxyprogesterone Acetate | 20 | $1,018 |
| Diazepam | 55 | $768 |
| Lacosamide | 19 | $693 |
| Metoclopramide Hcl | 31 | $663 |
| Lactulose | 23 | $659 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $69 | $25,34624 claims |
| Boehringer IngelheimJardiance | $12 | $10,55614 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 614 internal medicine providers in Arkansas.
Other internal medicine in Fort Smith
- Tyree SealsFort Smith$14K
- Hubert LandersFort Smith$7K
- Brent ReevesFort Smith$6K
- Beena SyedFort Smith$6K
- Sumer PhillipsFort Smith$6K
- Becky YarboroughFort Smith$6K
- Zain SharifFort Smith$5K
- David PyleJonesboro$93K
- Aaron StrobelLittle Rock$32K
- Stuart BensonRogers$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.